We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Chiral Quest Subsidiary Signs License Agreement with

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Chiral Quest Subsidiary Signs License Agreement with"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

VioQuest's subsidiary Chiral Quest, Inc., (VQPH) signed a licensing agreement granting Merck & Co., Inc. use of its catalysts for the process development and manufacture of single-enantiomer intermediates and active pharmaceutical ingredients.

This agreement provides Merck with access to a broad range of proprietary ligands and catalysts.